RecruitingPhase 2NCT06456359

Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor

Studying Desmoplastic small round cell tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital Heidelberg
Principal Investigator
Richard F. Schlenk, Professor, MD
National Center for Tumour Diseases, University Hospital Heidelberg
Intervention
Signifor(drug)
Enrollment
28 enrolled
Eligibility
13-50 years · All sexes
Timeline
20242028

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06456359 on ClinicalTrials.gov

Other trials for Desmoplastic small round cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Desmoplastic small round cell tumor

← Back to all trials